Erlotinib Response in an NSCLC Patient with a Novel Compound G719D+L861R Mutation in EGFR

Title
Erlotinib Response in an NSCLC Patient with a Novel Compound G719D+L861R Mutation in EGFR
Authors
Keywords
-
Journal
Journal of Thoracic Oncology
Volume 8, Issue 9, Pages e83-e84
Publisher
Elsevier BV
Online
2013-08-15
DOI
10.1097/jto.0b013e31829ceb8d

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now